Anticoagulation in critically ill patients with isolated distal deep vein thrombosis: a retrospective cohort study
Early low-dose anticoagulation can reduce the risk of thrombus propagation in critically ill patients with IDDVT without increasing bleeding risk, but caution should be exercised in those with active malignant tumor, trauma or an IMPROVE score ≥ 7, given their inherently high bleeding risk.
Authors
- Hong Chen (ORCID: https://orcid.org/0000-0001-7427-2031)
- Jiazhou Liu (ORCID: https://orcid.org/0000-0003-4541-0233)
- Binyan Fu
- Yuliang Liu (ORCID: https://orcid.org/0000-0002-6835-7597)
- Xiaohui Wang (ORCID: https://orcid.org/0000-0001-9180-5872)
- Shengxin Fan
Institutions
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- BMC Cardiovascular Disorders
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1186/s12872-025-05087-8
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chongqing Municipal Health Commission
- National Key Research and Development Program of China